PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
APC/Cy7 anti-human IL-17A, 100 tests
APC/Cy7 anti-human IL-17A, 25 tests
APC/Cy7 anti-human IL-2, 100 tests
APC/Cy7 anti-human IL-2, 25 tests
APC/Cy7 anti-human IL-4, 100 tests
APC/Cy7 anti-human IL-4, 25 tests
APC/Cy7 anti-human TNF-α, 100 tests
APC/Cy7 anti-human TNF-α, 25 tests
APC/Fireª 750 anti-human IFN-γ
Biotin anti-human Adiponectin (Acrp30), 50 μg
Biotin anti-human Adiponectin (Acrp30), 500 μg
Biotin anti-human APRIL (TNFSF13, CD256), 50 μg
Biotin anti-human APRIL (TNFSF13, CD256), 500 μg
Biotin anti-human C3a/C3a(desArg)/C3, 50 μg
Biotin anti-human C3a/C3a(desArg)/C3, 500 μg
Biotin anti-human C5a/C5a(desArg)/C5, 50 μg